On 730 Polk Street in the Tenderloin neighborhood of San Francisco sits a safe syringe access center, St. James Infirmary, where clean syringes and other drug use supplies are provided every Tuesday evening. Narcan—a lifesaving drug that reverses the effects of an overdose—is also distributed.
A federal judge ruled Dec. 20 that the city of Anchorage, Alaska, cannot force a local faith-based women’s shelter to accept trans-identified biological males.
Eight of the nine Supreme Court justices are Catholics or Jews—groups historically victimized by religious discrimination. Yet the court’s emerging leader in defending religious freedom is its only mainline Protestant.
Newsweek review of financial filings in Congress has found that lawmakers who are driving legislation to protect Uyghurs in China are also invested—either directly in the form of stocks, or indirectly via mutual funds—in major companies tied to the oppression in Xinjiang.
The fact that the FBI has lost its way has been on public display for at least five years now. Truth be told, it probably strayed off course way before that. But during the Trump Presidency, it became too obvious to ignore.
House Minority Leader Kevin McCarthy (R-CA) plans to launch at least seven investigations into Democrat President Joe Biden’s administration if Republicans win back control of the House of Representatives in 2022, which is expected.
U.S. drug agents are expanding operations in China – six years after America’s largest trading partner and global rival emerged as the main source of chemicals used to make highly lethal fentanyl. It’s now claiming 65,000 American lives a year.
